Archives of physical medicine and rehabilitation · 2003
An ankle-foot orthosis with inhibitor bar: effect on hemiplegic gait.
Сравнительное исследованиеСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Iwata Manabu, Kondo Izumi, Sato Yoshihiro, Satoh Kei, Soma Masashi, Tsushima Eiki
Аннотация
OBJECTIVE: To test whether an inhibitor bar attached to an ankle-foot orthosis (AFO) improves walking ability in hemiplegic stroke patients with tonic toe flexion reflex (TTFR).
DESIGN: Before-after trial.
SETTING: Rehabilitation hospital in Japan.
PARTICIPANTS: Nine patients with TTFR were assigned to the TTFR group, and 8 patients without TTFR were assigned to the control group.
INTERVENTION: Inhibitor bar attached to an AFO.
MAIN OUTCOME MEASURE: Gait was analyzed by measuring the number of steps and the time required to walk 10m at a maximal walking speed.
RESULTS: In the TTFR group, use of an inhibitor bar for 2 weeks significantly increased the maximal walking speed, stride length, and cadence by 13.8% (P=.0045), 8.0% (P=.0398), and 6.1% (P=.0056), respectively. There were no significant changes in the control group.
CONCLUSION: An inhibitor bar improved walking ability of hemiplegic patients with TTFR, and its use with an AFO is recommended.
DESIGN: Before-after trial.
SETTING: Rehabilitation hospital in Japan.
PARTICIPANTS: Nine patients with TTFR were assigned to the TTFR group, and 8 patients without TTFR were assigned to the control group.
INTERVENTION: Inhibitor bar attached to an AFO.
MAIN OUTCOME MEASURE: Gait was analyzed by measuring the number of steps and the time required to walk 10m at a maximal walking speed.
RESULTS: In the TTFR group, use of an inhibitor bar for 2 weeks significantly increased the maximal walking speed, stride length, and cadence by 13.8% (P=.0045), 8.0% (P=.0398), and 6.1% (P=.0056), respectively. There were no significant changes in the control group.
CONCLUSION: An inhibitor bar improved walking ability of hemiplegic patients with TTFR, and its use with an AFO is recommended.